WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3'1301 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 2'9911 Child (under 5 years) mortality rate: 182

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 258  253  247  242  236  185  147  116 
Births
Surviving infants
Pop. less than 5 years 33  34  35  35  34  28  24  19 
Pop. less than 15 years 94  94  93  92  90  77  64  51 
Female 15-49 years 65  64  62  61  60  45  34  26 

Number of reported case

(Click for retrospective incidence data for Vanuatu)
Diphtheria
Japanese encephalitis
Measles 10  67  39 
Mumps
Pertussis 36  231 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Vanuatu)
Vaccine year result method % card seen                                                
BCG 2012  73  DHS   57  95  89  99*  93  90  99  96 
DTP1 2012  76  DHS   57  95  87  99*  99*  95 
DTP3 2012  55  DHS   57  86  75  95  92  93  90  76 
HepB_BD          80  76  79  73  63 
HepB3 2012  55  DHS   57  86  75  95  92  90  75 
Hib3 2012  55  DHS   57  86  75  95  92 
JapEnc         
MCV          90  65  94  92  82  94  66 
MCV2         
PCV1         
PCV3         
Pol3 2012  52  DHS   57  80  75  95  89  90  87  78 
Rota1         
Rota_last         
Rubella1         
TT2plus 2012  30  DHS   57  25  63  88  88  43 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Vanuatu)
BCG 81  81  81  81  79  96 
DTP1 78  78  78  78  85  91 
DTP3 68  68  68  68  71  76 
HepB3 59  59  59  59  70 
HepB_BD
Hib3 68  68  68 
MCV 52  52  52  52  61  66 
MCV2
PAB 75  75  75  73  86  47 
PCV3
Pol3 67  67  67  67  67  78 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
94 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
Measles 1 year; Yes
OPV 6, 10, 14 weeks; 6, 12 years; Yes
TT 1st contact; +2, +6 months; +1, +2 years; Yes
Td 6, 12 years; Yes
VitaminA , 12, 18, 24 months;

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  Yes  Yes  Yes  No  Yes 
What years does the MYP cover? number   5yrs    2010-2015  2010-2014    2'010 
Nº of districts with microplans that include activities to raise immunization coverage number    

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100%   17  83  67  67  67 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100%   33    33   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No    No  Yes  No  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 25    80    6'000    100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.